ROYAL BANK OF CANADA - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 39 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,000
+50.0%
1,056
+25.0%
0.00%
Q1 2024$2,000
-33.3%
845
-21.9%
0.00%
Q4 2023$3,000
+50.0%
1,082
+34.4%
0.00%
Q3 2023$2,000
-33.3%
805
-8.9%
0.00%
Q2 2023$3,000
+200.0%
884
+9.8%
0.00%
Q1 2023$1,0000.0%8050.0%0.00%
Q4 2022$1,0000.0%805
-30.6%
0.00%
Q3 2022$1,000
-50.0%
1,160
+44.1%
0.00%
Q2 2022$2,0000.0%8050.0%0.00%
Q1 2022$2,000
-33.3%
8050.0%0.00%
Q4 2021$3,000
-66.7%
805
-65.1%
0.00%
Q3 2021$9,000
-10.0%
2,3050.0%0.00%
Q2 2021$10,000
-41.2%
2,305
+27.7%
0.00%
Q1 2021$17,000
+112.5%
1,805
+113.4%
0.00%
Q4 2020$8,000
-27.3%
846
-68.7%
0.00%
Q3 2020$11,000
-31.2%
2,699
+11.8%
0.00%
Q2 2020$16,000
+128.6%
2,415
-13.7%
0.00%
Q1 2020$7,000
-36.4%
2,799
+19.3%
0.00%
Q4 2019$11,000
+120.0%
2,347
+6.9%
0.00%
Q3 2019$5,000
-50.0%
2,196
+13.8%
0.00%
Q2 2019$10,000
+11.1%
1,9300.0%0.00%
Q1 2019$9,000
+800.0%
1,930
+283.7%
0.00%
Q4 2018$1,0005030.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 500,000$1,420,0003.26%
Altium Capital Management LP 287,698$817,0620.56%
Bleichroeder LP 222,317$631,3800.14%
COOPERMAN LEON G 1,767,246$5,018,9780.12%
Aristides Capital LLC 106,333$301,9860.11%
CATALYST FINANCIAL PARTNERS LLC 36,267$102,9980.03%
Naples Money Management LLC 3,878$11,0140.01%
Stonebridge Capital Advisors LLC 20,000$56,8000.01%
Legend Financial Advisors, Inc. 1,000$2,8400.00%
FIRST MANHATTAN CO. LLC. 114,744$325,8720.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders